XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 100 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,595 | -28.7% | 151,395 | 0.0% | 0.02% | -28.6% |
| Q2 2023 | $395,141 | +61.1% | 151,395 | 0.0% | 0.02% | +50.0% |
| Q1 2023 | $245,260 | +22.7% | 151,395 | 0.0% | 0.01% | +180.0% |
| Q4 2022 | $199,841 | -15.3% | 151,395 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $236,000 | +1.7% | 151,395 | 0.0% | 0.01% | -25.0% |
| Q2 2022 | $232,000 | -40.2% | 151,395 | 0.0% | 0.01% | -38.5% |
| Q1 2022 | $388,000 | -12.0% | 151,395 | 0.0% | 0.01% | -7.1% |
| Q4 2021 | $441,000 | – | 151,395 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $15,460,000 | 19.22% |
| Stonepine Capital Management, LLC | 7,924,056 | $20,286,000 | 8.41% |
| ARMISTICE CAPITAL, LLC | 7,464,993 | $19,110,000 | 0.37% |
| NEA Management Company, LLC | 3,246,785 | $8,312,000 | 0.24% |
| Alpine Global Management, LLC | 633,040 | $1,620,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 248,000 | $635,000 | 0.11% |
| Redmile Group, LLC | 1,046,587 | $2,679,000 | 0.08% |
| CTC Capital Management, LLC | 11,800 | $30,000 | 0.08% |
| TUDOR INVESTMENT CORP ET AL | 961,192 | $2,461,000 | 0.06% |
| Yakira Capital Management, Inc. | 117,076 | $300,000 | 0.04% |